Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03099109
Title A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
The University of Arizona Cancer Center Tucson Arizona 85719 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Columbia University College of Phys & Surgeons New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Peggy and Charles Stephenson Oklahoma Cancer Center Oklahoma City Oklahoma 73104 United States Details
Sarah Cannon Research Institute SCRI Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
The START Center for Cancer Care San Antonio Texas 78229 United States Details
National Cancer Center Hospital East Kashiwa Chiba 277 8577 Japan Details
National Cancer Center Hospital Chuo-Ku Tokyo 104-0045 Japan Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Severance Hospital Yonsei University Health System Seoul 03722 Korea, Republic of Details
Hospital Clinico Universitario Virgen de la Victoria Malaga Andalucia 29010 Spain Details
Fundación Jiménez Díaz-Oncology Madrid 28040 Spain Details
Hospital Madrid Norte Sanchinarro Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field